Description: After the hit taken by Mylan Inc. last week for its sixfold increase in the price of the lifesaving EpiPen, Umer Raffat, an analyst at Evercore ISI, has been receiving a certain request: Investors want to know which companies are making similar moves.
Date: Sep 02, 2016
Questions for Discussions:
- What does the report say about the industry and pricing strategies?
- Why do you think the industry is able to raise prices as it does?
- What does this environment mean for investors?